Copyright
©The Author(s) 2019.
World J Stem Cells. Nov 26, 2019; 11(11): 968-981
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.968
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.968
Gafni et al[48] | Chan et al[49] | Valamehr et al[50] | Ware et al[51] | Theunissen et al[120] | Guo et al[47] | Ying et al[42] | Yang et al[15] | Yang et al[15] | Yang et al[14] | |
Naive hESC | Naive hESC | Naive hESC | Naive hESC | Naive hESC | Naive hESC | Naive mESC | hEPSC | mEPSC | mEPSC | |
MEK inhibitor | PD0325901 | PD0325901 | PD0325901 | PD0325901 | PD0325901 | PD0325901 | PD0325901 | - | - | PD0325901 |
GSK3 inhibitor | CHIR 99021 | BIO | CHIR99021 | CHIR99021 | IM-12 | CHIR99021 | CHIR99021 | CHIR99021 | CHIR99021 | CHIR99021 |
LIF | + | + | + | + | + | + | + | + | + | - |
FGF2 | + | + | + | + | - | - | - | - | - | - |
TGFβ | + | + | - | Activin | Activin | - | - | - | - | - |
ROCK Inhibitor | Y27632 | Thiazovivin | Thiazovivin | Y27632 | Y27632 | Y27632 | - | Y27632 | - | - |
Insulin | + | + | - | - | - | + | - | - | - | - |
Other factors | JNKi; p38i; PKCi | Dorsomorphin | TGFi | TGFi; FGFRi; HDACi, STAT3i | B-RAFi; LCK/SRCi | PKCi | - | IWR1, dimethindene maleate, minocycline hydrochloride | Dimethindene maleate, minocycline hydrochloride | p38i, JNKi; SRCi; Tanki, WNTi |
Base medium | KO DMEM | DMEM/F12 | DMEM/F12 | DMEM/F12 | DMEM/F12/ Neurobasal | DMEM/F12/ Neurobasal | DMEM/F12 | DMEM/F12/Neurobasal | DMEM/F12/Neurobasal | DMEM/F12 |
Medium Supplement | KOSR, NEAA, AlbuMAX I, L-glutamine, BME | TeSR1 components | KOSR, NEAA, BME, L-glutamine | GlutaMAX, KOSR, NEAA, BME, sodium pyruvate | B27/N2, L-glutamine, NEsAA, BME, BSA | N2/B27, L-glutamine, BME, Vc, selenium, putrescine, proges-terone | N2/B27 | N2/B27, GlutaMAX, BME, BSA, KOSR | N2/B27, GlutaMAX, BME, BSA, KOSR | BME, GPS, NEAA, KOSR |
Feeder | MEF optional | MEF | - | - | MEF | MEF | - | MEF | MEF | MEF |
Coating | Gelatin/vitronectin | Matrigel | Matrigel/vitronectin | Matrigel | - | - | Gelatin | - | - | - |
Markers | Surface markers[121]: CD7, CD77, CD75, CD130 | Oct4, Nanog, Rex1 | OCT4, KLF4, NANOG | Oct4, Nanog, Sox2, Sall4 | Oct4, Nanog, Sox2, Klf4, Rex1, Esrrb | |||||
Nuclear markers[119]: OCT4, NANOG, SOX2, KLF4,5,17, TFCP2L1, DPPA3,5 |
- Citation: Liu W, Deng C, Godoy-Parejo C, Zhang Y, Chen G. Developments in cell culture systems for human pluripotent stem cells. World J Stem Cells 2019; 11(11): 968-981
- URL: https://www.wjgnet.com/1948-0210/full/v11/i11/968.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v11.i11.968